Coordination of a Multidisciplinary and Adaptive Toolbox Expedites HIV/Hepatitis C (HCV) Co-infection Eradication
Resource (Conference Presentation) updated 09/14/2023
Resource (Conference Presentation) updated 09/14/2023
Resource (Conference Presentation) updated 09/14/2023
In this workshop, participants will gain resources and strategies for implementing community engagement programs, including training community health workers to be part of a health care team to enhance viral suppression and management of HIV in rural populations.
Resource (Conference Presentation) updated 09/14/2023
This session will provide a close look at a replicable care model, an internal medicine-based federally qualified health center (FQHC) patient-centered medical home (PCMH) mobile clinic that receives Ryan White Part C funding.
Resource (Conference Presentation) updated 09/14/2023
In a multi-site community health center system, the most challenging patients with HIV and hepatitis C (HCV) co-infection were assessed for HICV cure, and the solutions developed to overcome their barriers to treatment were translated into systems change. The presenters will discuss the challenges, solutions, and resultant system changes.
Resource (Conference Presentation) updated 09/14/2023
Resource (Conference Presentation) updated 09/14/2023
Resource (Conference Presentation) updated 09/14/2023
Resource (Conference Presentation) updated 09/14/2023
Resource updated 03/15/2023
Resource from the RWHAP Best Practices Compilation updated on 01/07/2024
Resource updated 12/22/2023
Resource updated 04/11/2023
Resource updated 06/27/2024
Resource from the RWHAP Best Practices Compilation updated on 01/03/2024
Resource from the RWHAP Best Practices Compilation updated on 11/26/2023
Resource updated 05/15/2024
Resource from the RWHAP Best Practices Compilation updated on 05/15/2024
Resource (Conference Presentation) updated 09/14/2023
Resource updated 05/09/2024
Barriers and facilitators to HCV treatment during the DAA era for the understudied and high-risk population of HIV/HCV co-infected patients who delay or do not consent to treatment, and interventions for increasing DAA treatment uptake.
Resource (Conference Presentation) updated 09/14/2023